Copy of Order dated 10-MAY-2013 rendered by The Honourable Madam Justice Snider placed on file. Original filed on Court File No. T-599-11

Communication to the Court from the Registry dated 30-APR-2013 re: Submissions on Costs (re: Order of February 18, 2013)

Affidavit of service of Daniel Cappe sworn on 24-APR-2013 on behalf of Respondent confirming service of Doc. No. 39 upon Applicant and respondent Minister of Health by email on 24-APR-2013 filed on 24-APR-2013

Reply Submissions on behalf of respondents Apotex Inc. and Teva Canada Ltd. (jointly) in response to the opposing submissions doc. No. 37 to the Motion in writing Filed on 24-APR-2013

Solicitor's certificate of service on behalf of Alex Gloor confirming service of Applicant's Responding Submissions on Costs (Doc 37) upon Respondent by email / courier on 24-APR-2013 filed on 24-APR-2013

Written Submissions in Response on behalf of Applicant Novartis Pharmaceuticals Canada concerning costs filed on 24-APR-2013

Solicitor's certificate of service on behalf of Andrew McIntyre confirming service of Doc. No. 35 upon Applicant and respondent Minister of Health by telecopier on 09-APR-2013 filed on 09-APR-2013

Written Submissions on behalf of respondent, Teva Canada concerning costs filed on 09-APR-2013

Solicitor's certificate of service on behalf of Marc Richard confirming service of the Costs Submissions upon Respondent (Teva Canada Limited) by email, on consent, (with hard copy to follow via courier) on 10-APR-2013 confirming service the Costs Submissions upon Respondent (Apotex Inc.) by email and hard copy via courier on 09-APR-2013 filed on 09-APR-2013

Joint Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 09-APR-2013

Written Submissions on behalf of Applicant concerning costs (pursuant to the Reasons for Judgement of Snider, J. dated 8-feb-13) filed on 09-APR-2013

Copy of Notice of Appeal (Appeal Court File No. A-99-13 ) appealing the Judgment of Justice Snider dated February 8, 2013 filed in the Court of Appeal on 19-MAR-2013 on behalf of Teva Limited placed on file on 08-APR-2013

Traduction certifiée (texte français) du jugement rendu(e) le 08-FEV-2013 par Madame le juge Snider déposée le 04-AVR-2013 en vertu de l'article 20 de la Loi sur les langues officielles inscrit(e) dans le livre J. & O., volume 1189 page(s) 73 - 74

Copy of Reasons for Judgemnt (Public) dated 19-FEB-2013 rendered by The Honourable Madam Justice Snider placed on file. Original filed on Court File No. T-599-11

Memorandum to file from Benoit Labelle dated 21-FEB-2013 re: Forwarding final decisions to the CMJ, Prothonotary Tabib. placed on file.

****** CANCELLED ****** Reasons for Judgment (Public) dated 19-FEB-2013 rendered by The Honourable Madam Justice Snider The Court's decision is with regard to Trial of the matter Filed on 19-FEB-2013 Same reasons also filed in T-599-11

Copy of Direction dated 19-FEB-2013 rendered by The Honourable Madam Justice Snider placed on file. Original filed on Court File No. T-599-11

Copy of Order dated 19-FEB-2013 rendered by The Honourable Madam Justice Snider placed on file. Original filed on Court File No. T-2021-10

Acknowledgment of Receipt received from all parties with respect to Direction, Judgment and Confidential Reasons for Judgment placed on file on 11-FEB-2013

Copy of Reasons for Judgment - Confidential dated 08-FEB-2013 rendered by The Honourable Madam Justice Snider placed on file. Original filed on Court File No. T-599-11

Judgment dated 08-FEB-2013 rendered by The Honourable Madam Justice Snider Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: granted Filed on 08-FEB-2013 entered in J. & O. Book, volume 1183 page(s) 281 - 282 Final Decision

Copy of Direction dated 08-FEB-2013 rendered by The Honourable Madam Justice Snider placed on file. Original filed on Court File No. T-599-11

Acknowledgment of Receipt received from Mr. Brodkin for Apotex, Mr. Stainsby for Teva and Mr. Creber for Novartis with respect to Confidentiality Order dated February 1, 2013 placed on file on 01-FEB-2013

Copy of Confidentiality Order dated 01-FEB-2013 rendered by The Honourable Madam Justice Snider placed on file. Original filed on Court File No. T-2021-10

Copy of Direction dated 20-DEC-2012 rendered by The Honourable Madam Justice Snider placed on file. Original filed on Court File No. T-2021-10

Toronto 07-NOV-2012 BEFORE The Honourable Madam Justice Snider Language: E Before the Court: Judicial Review Result of Hearing: Matter reserved held in Court Senior Usher: Sybil Mirosolin Duration per day: 07-NOV-2012 from 02:00 to 04:28 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz 09-NOV-2012 from 11:55 to 02:55 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Jake Schutz Total Duration: 1d Appearances: Anthony Creber 613-233-1781 representing Applicant Isabel Raasch 613-233-1781 representing Applicant John Norman 613-233-1781 representing Applicant Jennifer Wilkie 613-233-1781 representing Applicant Andrew Brodkin 416-979-2211 representing respondent (Apotex Inc.) Daniel Cappe 416-979-2211 representing respondent (Apotex Inc.) Dino Clarizio 416-979-2211 representing respondent (Apotex Inc.) Jonathan Stainsby 416-360-6336 representing respondent (Teva Canada Ltd.) Court Reporter: Sandra Brereton 416-861-8720 07-NOV-2012 Sandra Brereton 416-861-8720 09-NOV-2012 Transcript requested (on an expedited basis) Comments: The application comprised approximately 1d of argument by both parties during the course of closing arguments on the action in T-833-11 and T-2021-10. The relevant evidence from that trial will be used to dispose of the application on this file. TO view main minutes of this matter, please refer to T-833-11 vol. 870 pp. 460-493 Minutes of Hearing entered in Vol. 871 page(s) 17 - 18 Abstract of Hearing placed on file

Day book of references and evidence submitted on behalf of Novartis Pharma Canada Inc. received at hearing on 07-NOV-2012

Compendium of evidence and authorities of the respondents received on 05-NOV-2012

Memorandum of fact and law on behalf of Respondent filed on 02-NOV-2012 1 judges' copies retained by the local office

Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of 27 upon counsel for the Respondents Teva & the Minister by electronically on consent with hard copy to follow via courier on 01-NOV-2012 filed on 01-NOV-2012

Memorandum of fact and law on behalf of Applicant filed on 01-NOV-2012 1 judges' copies stored in Ottawa

Covering letter from Applicant dated 12-SEP-2012 concerning Doc. Nos. 25 26 placed on file on 12-SEP-2012

Solicitor's certificate of service on behalf of Jennifer Wilkie confirming service of doc. no. 25 upon Respondent, Apotex Inc. by courier on 11-SEP-2012 confirming service doc. no. 25 upon Respondent, the Minister of Health by courier on 11-SEP-2012 filed on 12-SEP-2012

Trial Record on behalf of Applicant filed on 12-SEP-2012

****** CANCELLED ****** Solicitor's certificate of service on behalf of Isabel Jaen Raasch confirming service of Book of Authorities upon all parties by courier on 10-FEB-2012 filed on 13-FEB-2012

****** CANCELLED ****** Book of Authorities consisting of 1 volume(s) on behalf of Defendant (Plaintiff by Counterclaim) received on 13-FEB-2012

Mediation Brief on behalf of Novartis AG filed on 19-DEC-2011

Amended PROTECTIVE ORDER (granting motion doc.17) rendered on 13-DEC-2011 by Mireille Tabib, Prothonotary filed on 13-DEC-2011 Matter considered without personal appearance amending DOC. 16 rendered October 18, 2011 entered in J. & O. Book, volume 1143 page(s) 273 - 286 Interlocutory Decision certified copies sent to parties Transmittal letters placed on file.

Communication to the Court from the Registry dated 06-DEC-2011 re: Motion to amend the protective order, on consent

Covering letter from Novartis (COPY) dated 05-DEC-2011 concerning their motion to amend the Protective Order placed on file on 05-DEC-2011

Motion Record containing the following original document(s): 17 18 19 20 Number of copies received: 1 on behalf of Plaintiff filed on 05-DEC-2011

Affidavit of Dr. Andreas Länzlinger sworn on 30-NOV-2011 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 17 with Exhibits A-E filed on 05-DEC-2011

Sealed envelope pursuant to Protective Confidentiality Order issued on October 18 and 19, 2011 on behalf of Plaintiff purporting to contain Affidavit of Peter Roth, sworn on November 29, 2011, with exhibits A-E Filed on 05-DEC-2011

Consent on behalf of all parties to the Protective Order set out as Schedule "B" filed on 05-DEC-2011

Notice of Motion contained within a Motion Record on behalf of Plaintiff in writing to be placed before the Court in Ottawa for an Order 1. amending the protective orders issued on October 18 in T-2021-10 and T-679-11 and October 19, 2011 in T-833-11 and T-599-11 in these proceedings protecting and maintaining the confidentiality of certain documents, information and transcripts to be produced by the parties during the course of these proceedings in accordance with the draft Orders attached hereto as Schedule « A » and Schedule « B ». filed on 05-DEC-2011

PROTECTIVE ORDER dated 18-OCT-2011 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: granted (Prottective Order rendered in T-2021-10 and T-679-11) Filed on 18-OCT-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1138 page(s) 51 - 64 Interlocutory Decision

Copy of Solicitor's Certificate dated 18-OCT-2011 placed on file on 18-OCT-2011 Original filed on Court File No. T-2021-10

Book of Authorities consisting of 1 volume(s) on behalf of Applicant (respondent/patentee) received on 18-OCT-2011

Letter from The Minister of Health dated 28-JUL-2011 advising the Court that Eric Peterson now has carriage of this file. received on 28-JUL-2011

Order dated 30-MAY-2011 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Letter from Plaintiff dated 26-MAY-2011 re: approving the draft order resolving motion docs. 20, 23 and 33 in T-2120-10 and Apotex's oral motion in T-599-11 Result: (see details of Order in Doc. 52 in T-2021-10) T-2021-10 and T-833-11 are Consolidated for the purposes of the trial (pleadings remain seperate) Filed on 30-MAY-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1125 page(s) 102 - 106 Interlocutory Decision

Ottawa 31-MAY-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss scheduling of T-2021-10 and T-833-11 Result of Hearing: Order to issue held in chambers by way of Conference Call Duration per day: 31-MAY-2011 from 02:00 to 03:10 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 1h10min Appearances: J. Stainsby/A.Skodyn 416-360-3568 representing Teva Canada J. Wilkie/A. Howard 613-786-0156 representing Novartis A. Brodkin/D. Cappe 416-597-4278 representing Apotex Inc. Comments: See abstract of hearing in T-2021-10 for further details. Minutes taken in T-2021-10 J&O vol. 844, pages 451-457 Minutes of Hearing entered in Vol. 844 page(s) 477 - 478 Abstract of Hearing placed on file

Letter from Respondent (Teva) dated 26-MAY-2011 I write on the agreement of counsel for all parties in the above matters to advise that the draft order prepared by the Court on May 16, 2011 has been approved by all parties. received on 26-MAY-2011

Written directions received from the Court: Mireille Tabib, Prothonotary dated 16-MAY-2011 directing that "As counsel for the parties will be seeking their respective client's approval of the draft order proposed at today's hearing, the Court wishes to remind the parties that dates for a a trial in T-2021-10 in Septmber 2012 have been requested, but that the Court has not committed to such dates being available and does not yet know whether they will be. Any consent given by the parties to the proposed darft order should not therefore be dependant or contingent on the date(s) on which the trial is to be fixed. If the parties cannot give their consent without being certain of the dates to be fixed for trial, they are to advise the Court and each other as soon as possible." placed on file on 16-MAY-2011 Confirmed in writing to the party(ies)

Ottawa 16-MAY-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 12 on behalf of Novartis Result of Hearing: Counsel discussed the motion to stay, but did not argue the motion. The Court has drafted an order for counsel to present to their clients for approval. Before the Court: Motion Doc. No. 13 on behalf of Novartis to consolidate the evidentiary schedules in T-2021-10, T-679-11 and T-599-11 Result of Hearing: Counsel discussed the motion, but did not argue it. The Court has drafted an Order for counsel to present to their clients for approval. held in Court Senior Usher: Brian Cooper Duration per day: 16-MAY-2011 from 09:30 to 03:00 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 5.5h Appearances: J. Stainsby/A. Skodyn 416-360-3568 representing Teva J. Norman/J. Wilkie 613-783-8848 representing Novartis A. Brodkin/D. Cappe 416-597-4278 representing Apotex Inc. in T-599-11 Comments: Minutes of Hearing taken in T-2021-10: Vol 843, Pages 476-486 See abstract of Hearing in T-2021-10 for further details Minutes of Hearing entered in Vol. 843 page(s) 494 - 495 Abstract of Hearing placed on file

Ottawa 06-MAY-2011 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss 3 motions in T-2021-10, T-599-11 and T-679-11 being heard May 16, 2011. Minutes taken in T-2021-10, vol. 843, pgs. 233-236. Result of Hearing: Direction to follow for schedule of Motion doc. 33 in T-2120-10. held in chambers by way of Conference Call Duration per day: 06-MAY-2011 from 01:25 to 02:45 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 20min Appearances: J. Stainsby/L. Caswell 416-360-3568 representing Teva J. Norman/A. Creber/Ms. Raasch 613-783-8848 representing Novartis A. Brodkin 416-597-4278 representing Apotex Inc. Minutes of Hearing entered in Vol. 843 page(s) 242 - 243 Abstract of Hearing placed on file

Written directions received from the Court: Mireille Tabib, Prothonotary dated 06-MAY-2011 directing that (See T-2120-10, ID: 85 for details) Schedule for Novartis' motion to consolidate being heard May 16, 2011. placed on file on 06-MAY-2011

Letter from Apotex (VIA E-MAIL) in reply to Direction of May 4, 2011 dated 05-MAY-2011 I am thus available at 1p.m. on May 6, 2011 should the Court wish to proceed as scheduled... received on 05-MAY-2011

Written directions received from the Court: Mireille Tabib, Prothonotary dated 05-MAY-2011 directing that A case management telephone conference will be held on May 6, 2011 at 1p.m. placed on file on 05-MAY-2011 Confirmed in writing to the party(ies)

Written directions received from the Court: Mireille Tabib, Prothonotary dated 04-MAY-2011 directing that 1. In reply to Mr. Clarizio's letter in T-599-11 dated May 3: "Apotex having requested, on April 26, 2011, a case managment conference "as soon as possible", declaring itself available "at the Court's convenience" but omitting to provide the Court with its opponent's availabilities, the Court acted accordingly in requesting Novartis' availabilities and fixing the date of May 6 in consequence. If Apotex is no longer available that date, the Apotex is to provide the Court with both counsel's availabilities, and the Court will then fix the date for the telephone conference. The case managment telephone conference scheduled for May 6, 2011 is adjourned." 2. In reply to Mr. Norman's letter of May 4 requesting leave to file one motion record for a consolidated schedule in T-2021-10 bearing all 3 styles of cause: "Leave is granted and the motion record may be filed as received, to avail for all 3 Court files." placed on file on 04-MAY-2011 Confirmed in writing to the party(ies)

Letter from Novartis dated 04-MAY-2011 requesting that the Court issue a direction to file their motion for a consolidated schedule in T-2021-10 bearing the styles of cause in T-2021-10, T-679-11 and T-599-11, and for the filing to be applied to the latter 2 files as well. received on 04-MAY-2011

Solicitor's certificate of service on behalf of John Norman confirming service of Doc. 13 upon Teva Canada Ltd. and The Minister of Health by telecopier on 03-MAY-2011 filed on 03-MAY-2011

Copy of Notice of Motion, filed in T-2021-10 on behalf of Novartis AG (in T-2021-10) returnable at Special Sitting in Ottawa on 16-MAY-2011 to begin at 02:00 for an Order consolidating the evidentiary schedules of T-2021-10 (Teva Action), T-599-11 (Apotex Application) and T-670-11 (Teva Application)...see doc. 33 in T-2021-10 for further details filed on 03-MAY-2011

Written directions received from the Court: Mireille Tabib, Prothonotary dated 03-MAY-2011 directing that (Rendered in T-599-11) "A case management telephone conference will take place at 1p.m. on May 6, 2011. The Applicants (in T-599-11)are to serve and file their full motion record as early as possible so that a schedule for hearing the motion can be fixed at the case management telephone conference. placed on file on 03-MAY-2011 Confirmed in writing to the party(ies)

Copy of a Letter from Teva in T-2021-10 dated 03-MAY-2011 in response to the letter from Novartis dated May 2, 2011 in T-599-11. Counsel for Teva wishes to attend the CMC in T-599-11 at 1p.m. on May 6... received on 03-MAY-2011

Copy of a Letter from Novartis in T-599-11 dated 02-MAY-2011 in response to Apotex's letter of April 26 and the Court's direction of the same date...Novartis believes that it would be prejudicial to consider any schedule in this proceeding before the issue of the stay is resolved in T-2021-10 and T-679-11...Novartis will be bringing a motion for a schedule whereby the schedule for evidence of the Apotex case will be consolidated with that of the Teva case(s)...we propose to file our Notice of Motion tomorrow and the remainder of the record by May 5, 2011. received on 02-MAY-2011

Covering letter from Teva Canada Ltd. dated 28-APR-2011 concerning Motion doc. 12 (see T-2021-10//Motion being heard 16-MAY-11) placed on file on 29-APR-2011

Notice of Motion on behalf of TEVA Canada Ltd. in file T-2021-10 returnable at Special Sitting in Ottawa on 16-MAY-2011 to begin at 02:00 for an Order pursuant to 50(1)(b) of the FC Act and/or 105(b) of the FC Rules staying the application in T-679-11 until the determination in action T-2021-10; In the alternative, an Order pursuant to 105(a) of the FC Rules that T-679-11 and the action T-2021-10 be consolidated; costs. (Note: The full motion record was filed in T-2021-10; see Order dated April 21, 2011) filed on 29-APR-2011

Affidavit of service of Mervyn Archdall sworn on 26-APR-2011 on behalf of Applicant confirming service of notice of application upon Teva Canada Limited by personal service on 20-APR-2011 filed on 27-APR-2011

Solicitor's certificate of service on behalf of Viktor Haramina confirming service of Notice of Appearance upon Applicant The Applicant, Novartis Pharmaceuticals Canada Inc by personal service on 21-APR-2011 confirming service Notice of Appearance upon The Respondent, Teva Canada Limited by fax on 21-APR-2011 confirming service Notice of Appearance upon The Respondent, the Minister of Health by Fax on 21-APR-2011 filed on 21-APR-2011

Copy of Order dated 21-APR-2011 rendered by Mireille Tabib, Prothonotary concerning motion to consolidate this application with T-2021-10. placed on file. Original filed on Court File No. T-2021-10

Notice of appearance on behalf of The Respondent Patentee, Novartis AG filed on 21-APR-2011

Acceptance of Service received from all parties vis e-mail on April 21, 2011 with respect to 8 placed on file on 21-APR-2011

Order dated 21-APR-2011 rendered by Chief Justice Lutfy Matter considered without personal appearance The Court's decision is with regard to Status Review Result: Pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 21-APR-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1121 page(s) 294 - 294 Interlocutory Decision

Covering letter from Respondent - Minister of Health dated 20-APR-2011 concerning Doc. Nos. 6 7 placed on file on 20-APR-2011

Affidavit of service of Nicholas Young sworn on 20-APR-2011 on behalf of Respondent-Minister of Health confirming service of Notice of Appearance upon Applicant Respondent and Respondent/Patentee by fax and by mail to Respondent/Patentee (Switzerland) on 20-APR-2011 filed on 20-APR-2011

Notice of appearance on behalf of Respondent - Minister of Health filed on 20-APR-2011

****** CANCELLED ****** Notice of appearance on behalf of the respondent filed on 20-APR-2011 with proof of service on the applicant the tribunal

Notice of appearance on behalf of Respondent(Teva Canada Limited) with proof of service upon Applicant on 20-APR-2011 Respondent(Minister of Health) on 20-APR-2011 Respondent(Novartis AG) on 20-APR-2011 filed on 20-APR-2011

Affidavit of service of Marcail Delahunt sworn on 19-APR-2011 on behalf of Applicant confirming service of the Notice of Application - Doc. 1 upon Respondent by personal service on 19-APR-2011 confirming service the Notice of Application - Doc. 1 upon Respondent/Patentee by personal service on 19-APR-2011 filed on 19-APR-2011

Service copy of Doc. No. 1 with proof of service upon Attorney General of Canada on 19-APR-2011 filed on 19-APR-2011

Notice of application and 2 copies with regard to Notice of Compliance under section 55.2(4) of the Patent Act filed on 18-APR-2011 Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes